The use of submucosal dexamethasone to minimise post-operative sequlae after third molar surgery

---

Original Article

Author Details : Sumedha , Mahendra P , Kumar S , Rakshak A.K , Bhatnagar A*, Sharma M

Volume : 2, Issue : 1, Year : 2014

Article Page : 14-24

Suggest article by email

Get Permission

---

Abstract

Purpose: The aim of this study is to evaluate the use of submucosal dexamethasone to minimize post operative sequelae after third molar surgery.

Materials and Methods: A total of ten patients including 6 females and 4 males in the age group of 22 to 32years who reported to the Department of Oral & Maxillofacial Surgery, 1.T.S Centre for Dental Studies and Research Muradnagar, Ghaziabad who required surgical removal of asymptomatic impacted mandibular third molars were included in this prospective study.

Results: We found that there was significant reduction in postoperative swelling,(p value 0.000), trismus (p value 0.000)in the patients in whome dexamethasone was administered, however there was no significant difference in the amount of pain(0.343,0.045,0.758) when compared immediate post operatively, 2”, 7° day post operatively.

Conclusion: With this information we can conclude that dexamethasone sodium phosphate (8mg) when administered preoperatively by submucosal route reduces the postoperative swelling, trismus in patients undergoing surgical removal of impacted lower third molar.

Keywords: Dexamethasone Sodium Phosphate, Third Molar Surgery.

How to cite : Sumedha, Mahendra P, Kumar S, A.k R, Bhatnagar A, Sharma M, The use of submucosal dexamethasone to minimise post-operative sequlae after third molar surgery. J Dent Spec 2014;2(1):14-24

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.